Comparitive study of Argon Laser and Aspirin in treatment of central serous chorioretinopathy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201706002163811

Enrollment

Registered

2017-03-31

Start date

2014-01-07

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eye Diseases Genetic Diseases Injury, Occupational Diseases, Poisoning Mental and Behavioural Disorders defective vision

Interventions

laser

aspirin alone

laser and aspirin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: central serous chorioretinopathy classic

Exclusion criteria

Exclusion criteria: within 500 Um from centre of fovea multifocal

Design outcomes

Primary

Measure	Time frame
laser with aspirin better than each alone;visual acuity	—

Countries

Egypt

Contacts

Public Contactgamal radwan

sohag faculty of medicine

gamalradwan8@gmail.com00201001244421

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026